XML 73 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss Attributable to Common Stockholders Per Share (Schedule of Antidilutive Securities) (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the calculation of net loss per share (in shares) 7,600,514 9,826,045 7,600,514 9,826,045
Convertible preferred stock (on an if-converted basis)        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the calculation of net loss per share (in shares) 0 0 0 0
Options to purchase common stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the calculation of net loss per share (in shares) 7,080,020 9,818,701 7,080,020 9,818,701
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the calculation of net loss per share (in shares) 0 0 0 0
Restricted shares of common stock related to early exercise of options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the calculation of net loss per share (in shares) 520,494 7,344 520,494 7,344
Warrants to purchase Series C convertible preferred stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the calculation of net loss per share (in shares) 0 0 0 0